Crigler-Najjar Syndrome: Clinical Trials

13 trials for Crigler-Najjar Syndrome, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 completed, 3 recruiting, 3 terminated, 1 unknown. 4 Phase 1, 3 Not applicable, 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 14Terminated 2, Completed 1, Recruiting 1
Not applicable3Completed 1, Recruiting 1, Unknown 1
Phase 23Recruiting 2, Completed 1

Follow Crigler-Najjar Syndrome: new trials by email Literature Review of Crigler-Najjar Syndrome trials Research Report on Crigler-Najjar Syndrome

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy and Safety of GNT0003 Following Imlifidase Pre-treatment in Severe Crigler-Najjar Syndrome
Imlifidase, GNT0003 - Crigler-Najjar Syndrome
Phase 2RecruitingGenethon32024-11-082024-12-03
Gene Therapy for Crigler Najjar Syndrome Type I (AlphaCN)
GT-UGT1A1-AAV8-02 - Crigler-Najjar Syndrome Type I
Phase 1 / Phase 2RecruitingFederal State Budget Institution Research Center for Obstetrics, Gynecology and Perinatology Ministry of Healthcare52024-11-062025-01-13
Baby Detect : Genomic Newborn Screening
Congenital Adrenal Hyperplasia, Familial Hyperinsulinemic Hypoglycemia 1
CompletedCentre Hospitalier Universitaire de Liege68242022-09-012025-08-12
HepaStem Long-Term Safety Registry
Urea Cycle Disorder, Crigler-Najjar Syndrome
TerminatedCellaion SA442018-04-042024-05-29
Gene Therapy for Severe Crigler Najjar Syndrome
GNT0003 - Crigler-Najjar Syndrome
Not applicableRecruitingGenethon172018-03-192023-03-28
Gene Transfer Clinical Study in Crigler-Najjar Syndrome
AT342 - Crigler-Najjar Syndrome
Phase 1TerminatedAudentes Therapeutics12017-09-082022-05-18
Clinical Assessment Study in Crigler-Najjar Syndrome
Crigler-Najjar Syndrome
CompletedAudentes Therapeutics82017-03-102019-02-06
New Phototherapy Device to Treat Patients With Crigler-Najjar Disease
Arm1 homemade phototherapy treatment, DRAP - Crigler Najjar Syndrome, Children
Not applicableUnknownAssistance Publique - Hôpitaux de Paris62014-12-012017-09-12
Immunity Against AAV in Crigler Najjar Patient
Blood sample for immunology - Crigler Najjar Syndrome
CompletedGenethon492014-11-012017-12-13
Long-term Safety Follow-up Study of Patients Having Received HepaStem (SAF001)
Urea Cycle Disorders, Crigler Najjar Syndrome
CompletedCellaion SA92013-03-012019-05-28
Safety Study of HepaStem for the Treatment of Urea Cycle Disorders (UCD) and Crigler-Najjar Syndrome (CN)
HepaStem - Urea Cycle Disorders, Crigler Najjar Syndrome
Phase 1 / Phase 2CompletedCellaion SA202012-03-012020-10-19
Hepatocyte Transplantation for Liver Based Metabolic Disorders
human hepatocyte transplantation, Preparative Radiation Therapy - Metabolic Diseases
Phase 1TerminatedIra Fox52011-03-012022-12-07
Orlistat Treatment of Crigler-Najjar Disease
orlistat - Crigler-Najjar Syndrome
Not applicableCompletedUniversity Medical Center Groningen162003-09-012007-04-18

Narrower conditions

Urea Cycle Disorders, Inborn (4)  ·  Carbamoyl-Phosphate Synthase I Deficiency Disease (2)  ·  Citrullinemia (2)  ·  Ornithine Carbamoyltransferase Deficiency Disease (2)  ·  3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency (1)  ·  3-Hydroxy-3-Methylglutaryl-CoA Synthase 2 Deficiency (1)  ·  Acidemia, isovaleric (1)  ·  Acute-On-Chronic Liver Failure (1)  ·  Acyl-CoA Dehydrogenase Family, Member 9, Deficiency of (1)  ·  Adrenal Hyperplasia, Congenital (1)  ·  Adrenoleukodystrophy (1)  ·  Andersen Syndrome (1)  ·  Anemia, Diamond-Blackfan (1)  ·  Anemia, Sickle Cell (1)

Broader conditions

Congenital, Hereditary, and Neonatal Diseases and Abnormalities (13)  ·  Genetic Diseases, Inborn (13)  ·  Hyperbilirubinemia, Hereditary (13)  ·  Metabolism, Inborn Errors (13)  ·  Nutritional and Metabolic Diseases (13)  ·  Metabolic Diseases (12)  ·  Amino Acid Metabolism, Inborn Errors (5)  ·  Brain Diseases (5)  ·  Brain Diseases, Metabolic (5)  ·  Brain Diseases, Metabolic, Inborn (5)  ·  Central Nervous System Diseases (5)  ·  Nervous System Diseases (5)  ·  Digestive System Diseases (2)  ·  Disease Attributes (2)  ·  Genetic Diseases, X-Linked (2)

Interventions

Blood Specimen Collection (1)  ·  Mac-1-like protein, Streptococcus (1)  ·  Orlistat (1)

Sponsors

Cellaion SA (3)  ·  Genethon (3)  ·  Audentes Therapeutics (2)  ·  Assistance Publique - Hôpitaux de Paris (1)  ·  Centre Hospitalier Universitaire de Liege (1)  ·  Federal State Budget Institution Research Center for Obstetrics, Gynecology and Perinatology Ministry of Healthcare (1)  ·  Ira Fox (1)  ·  University Medical Center Groningen (1)

Countries

France (6)  ·  Belgium (4)  ·  Israel (3)  ·  United Kingdom (3)  ·  United States (3)  ·  Italy (2)  ·  Netherlands (2)  ·  Bulgaria (1)  ·  Poland (1)  ·  Russia (1)  ·  Spain (1)

Top investigators

Anja M. Hafkamp, MD (1)  ·  Dries Dobbelaere, MD/Prof (1)  ·  Giuliano Torre, MD (1)  ·  Hanna Mandel, MD (1)  ·  Henkjan J. Verkade, MD, PhD (1)  ·  Ira J Fox, MD (1)  ·  Laurent Servais (1)  ·  Maarten Sinaasappel, MD (1)  ·  Stephanie Grunewald, MD (1)  ·  Suyash Prasad, M.D. (1)  ·  Suyash Prasad, MBBS, MRCP,MRCPCH, FFPM (1)

Results publications

PMID 22789058, PMID 32028991, PMID 37585628